Skip to site content

Medication Therapy

Session Title Session Material CME/CE Information
Diabetes Update: Roles and Benefits of SGLT-2 Inhibitors and GLP-1 Agonists Exit Disclaimer: You Are Leaving 
Paul Bloomquist, MD
Area Diabetes Consultant
Phoenix Area IHS

(Originally presented on 09/21/21.)
Pharmacovigilance: Timely Information Regarding Medication Safety Exit Disclaimer: You Are Leaving 
Chris Lamer, PharmD, MHS, BCPS, CDE
Director, Pharmacovigilance
IHS National Pharmacy and Therapeutics Committee

(Originally presented on 12/9/20.)